Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk

Su Yon Jung, Gloria Ho, Thomas E. Rohan, Howard Strickler, Jennifer Bea, Jeanette Papp, Eric Sobel, Zuo Feng Zhang, Carolyn Crandall

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Genetic variants and traits in metabolic signaling pathways may interact with obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal breast cancer risk, but these inter-related pathways are incompletely understood. Methods: We used 75 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) traits and signaling pathways, and data from 1003 postmenopausal women in Women’s Health Initiative Observation ancillary studies. Stratifying via obesity and lifestyle modifiers, we assessed the role of IGF-I/IR traits (fasting IGF-I, IGF-binding protein 3, insulin, glucose, and homeostatic model assessment-insulin resistance) in breast cancer risk as a mediator or influencing factor. Results: Seven SNPs in IGF-I and INS genes were associated with breast cancer risk. These associations differed between non-obese/active and obese/inactive women and between exogenous E non-users and users. The mediation effects of IGF-I/IR traits on the relationship between these SNPs and cancer differed between strata, but only roughly 35% of the cancer risk due to the SNPs was mediated by traits. Similarly, carriers of 20 SNPs in PIK3R1, AKT1/2, and MAPK1 genes (signaling pathways–genetic variants) had different associations with breast cancer between strata, and the proportion of the SNP–cancer relationship explained by traits varied 45–50% between the strata. Conclusions: Our findings suggest that IGF-I/IR genetic variants interact with obesity and lifestyle factors, altering cancer risk partially through pathways other than IGF-I/IR traits. Unraveling gene–phenotype–lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce breast cancer risk.

Original languageEnglish (US)
Pages (from-to)475-495
Number of pages21
JournalBreast Cancer Research and Treatment
Volume164
Issue number2
DOIs
StatePublished - Jul 1 2017

Fingerprint

Insulin-Like Growth Factor I
Insulin Resistance
Life Style
Breast Neoplasms
Single Nucleotide Polymorphism
Obesity
Neoplasms
Genes
Insulin-Like Growth Factor Binding Protein 3
Women's Health
Metabolic Networks and Pathways
Fasting
Estrogens
Observation
Clinical Trials
Exercise
Insulin
Glucose

Keywords

  • Breast cancer
  • Exogenous estrogen
  • Insulin-like growth factor-I/insulin resistance-related genetic variant
  • Obesity
  • Physical activity
  • Postmenopausal women

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk. / Jung, Su Yon; Ho, Gloria; Rohan, Thomas E.; Strickler, Howard; Bea, Jennifer; Papp, Jeanette; Sobel, Eric; Zhang, Zuo Feng; Crandall, Carolyn.

In: Breast Cancer Research and Treatment, Vol. 164, No. 2, 01.07.2017, p. 475-495.

Research output: Contribution to journalArticle

Jung, Su Yon ; Ho, Gloria ; Rohan, Thomas E. ; Strickler, Howard ; Bea, Jennifer ; Papp, Jeanette ; Sobel, Eric ; Zhang, Zuo Feng ; Crandall, Carolyn. / Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk. In: Breast Cancer Research and Treatment. 2017 ; Vol. 164, No. 2. pp. 475-495.
@article{3583be7e732c46a9b0a522877a804771,
title = "Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk",
abstract = "Purpose: Genetic variants and traits in metabolic signaling pathways may interact with obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal breast cancer risk, but these inter-related pathways are incompletely understood. Methods: We used 75 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) traits and signaling pathways, and data from 1003 postmenopausal women in Women’s Health Initiative Observation ancillary studies. Stratifying via obesity and lifestyle modifiers, we assessed the role of IGF-I/IR traits (fasting IGF-I, IGF-binding protein 3, insulin, glucose, and homeostatic model assessment-insulin resistance) in breast cancer risk as a mediator or influencing factor. Results: Seven SNPs in IGF-I and INS genes were associated with breast cancer risk. These associations differed between non-obese/active and obese/inactive women and between exogenous E non-users and users. The mediation effects of IGF-I/IR traits on the relationship between these SNPs and cancer differed between strata, but only roughly 35{\%} of the cancer risk due to the SNPs was mediated by traits. Similarly, carriers of 20 SNPs in PIK3R1, AKT1/2, and MAPK1 genes (signaling pathways–genetic variants) had different associations with breast cancer between strata, and the proportion of the SNP–cancer relationship explained by traits varied 45–50{\%} between the strata. Conclusions: Our findings suggest that IGF-I/IR genetic variants interact with obesity and lifestyle factors, altering cancer risk partially through pathways other than IGF-I/IR traits. Unraveling gene–phenotype–lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce breast cancer risk.",
keywords = "Breast cancer, Exogenous estrogen, Insulin-like growth factor-I/insulin resistance-related genetic variant, Obesity, Physical activity, Postmenopausal women",
author = "Jung, {Su Yon} and Gloria Ho and Rohan, {Thomas E.} and Howard Strickler and Jennifer Bea and Jeanette Papp and Eric Sobel and Zhang, {Zuo Feng} and Carolyn Crandall",
year = "2017",
month = "7",
day = "1",
doi = "10.1007/s10549-017-4272-y",
language = "English (US)",
volume = "164",
pages = "475--495",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk

AU - Jung, Su Yon

AU - Ho, Gloria

AU - Rohan, Thomas E.

AU - Strickler, Howard

AU - Bea, Jennifer

AU - Papp, Jeanette

AU - Sobel, Eric

AU - Zhang, Zuo Feng

AU - Crandall, Carolyn

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Purpose: Genetic variants and traits in metabolic signaling pathways may interact with obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal breast cancer risk, but these inter-related pathways are incompletely understood. Methods: We used 75 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) traits and signaling pathways, and data from 1003 postmenopausal women in Women’s Health Initiative Observation ancillary studies. Stratifying via obesity and lifestyle modifiers, we assessed the role of IGF-I/IR traits (fasting IGF-I, IGF-binding protein 3, insulin, glucose, and homeostatic model assessment-insulin resistance) in breast cancer risk as a mediator or influencing factor. Results: Seven SNPs in IGF-I and INS genes were associated with breast cancer risk. These associations differed between non-obese/active and obese/inactive women and between exogenous E non-users and users. The mediation effects of IGF-I/IR traits on the relationship between these SNPs and cancer differed between strata, but only roughly 35% of the cancer risk due to the SNPs was mediated by traits. Similarly, carriers of 20 SNPs in PIK3R1, AKT1/2, and MAPK1 genes (signaling pathways–genetic variants) had different associations with breast cancer between strata, and the proportion of the SNP–cancer relationship explained by traits varied 45–50% between the strata. Conclusions: Our findings suggest that IGF-I/IR genetic variants interact with obesity and lifestyle factors, altering cancer risk partially through pathways other than IGF-I/IR traits. Unraveling gene–phenotype–lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce breast cancer risk.

AB - Purpose: Genetic variants and traits in metabolic signaling pathways may interact with obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal breast cancer risk, but these inter-related pathways are incompletely understood. Methods: We used 75 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) traits and signaling pathways, and data from 1003 postmenopausal women in Women’s Health Initiative Observation ancillary studies. Stratifying via obesity and lifestyle modifiers, we assessed the role of IGF-I/IR traits (fasting IGF-I, IGF-binding protein 3, insulin, glucose, and homeostatic model assessment-insulin resistance) in breast cancer risk as a mediator or influencing factor. Results: Seven SNPs in IGF-I and INS genes were associated with breast cancer risk. These associations differed between non-obese/active and obese/inactive women and between exogenous E non-users and users. The mediation effects of IGF-I/IR traits on the relationship between these SNPs and cancer differed between strata, but only roughly 35% of the cancer risk due to the SNPs was mediated by traits. Similarly, carriers of 20 SNPs in PIK3R1, AKT1/2, and MAPK1 genes (signaling pathways–genetic variants) had different associations with breast cancer between strata, and the proportion of the SNP–cancer relationship explained by traits varied 45–50% between the strata. Conclusions: Our findings suggest that IGF-I/IR genetic variants interact with obesity and lifestyle factors, altering cancer risk partially through pathways other than IGF-I/IR traits. Unraveling gene–phenotype–lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce breast cancer risk.

KW - Breast cancer

KW - Exogenous estrogen

KW - Insulin-like growth factor-I/insulin resistance-related genetic variant

KW - Obesity

KW - Physical activity

KW - Postmenopausal women

UR - http://www.scopus.com/inward/record.url?scp=85018758119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018758119&partnerID=8YFLogxK

U2 - 10.1007/s10549-017-4272-y

DO - 10.1007/s10549-017-4272-y

M3 - Article

VL - 164

SP - 475

EP - 495

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -